Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1638
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19361281 | ADENO-ASSOCIATED VIRAL VECTOR COMPOSITIONS AND METHODS OF USE | Non-Final OA | Siren Biotechnology, Inc. |
| 18437160 | GENETICALLY MODIFIED MSC AND THERAPEUTIC METHODS | Final Rejection | The Regents of the University of California |
| 17351113 | METHODS FOR THE TREATMENT OF DANON DISEASE AND OTHER DISORDERS OF AUTOPHAGY | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17676338 | NON-HUMAN ANIMALS HAVING AN IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION THAT INCLUDES AN ENGINEERED DIVERSITY CLUSTER AND USES THEREOF | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17041252 | GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 16991283 | GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18459871 | MODEL OF SPINAL CORD HYPOPERFUSION AND ISCHEMIC STROKE WITH IMMEDIATE PARALYSIS | Non-Final OA | Ohio State Innovation Foundation |
| 18052113 | TRANSGENIC RABBIT WITH COMMON LIGHT CHAIN | Non-Final OA | Hoffmann-La Roche Inc. |
| 18006969 | BLADDER ORGANOID AND METHOD FOR PRODUCING SAME | Non-Final OA | OTSUKA PHARMACEUTICAL CO., LTD. |
| 17640585 | DEVELOPMENT OF EMBRYONIC-LIKE TISSUE FROM STEM CELLS | Final Rejection | The Regents of the University of Michigan |
| 16624081 | A METHOD OF TREATING EPIDERMOLYSIS BULLOSA USING MUSE CELLS | Non-Final OA | TOHOKU UNIVERSITY |
| 17763849 | SYSTEMS AND METHODS FOR BATCH CULTIVATION OF NON-TRANSGENIC HETEROGAMETES | Final Rejection | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 18015043 | TRANSGENIC MOUSE MODEL EXPRESSING HUMAN HLA-A201 RESTRICTION GENE | Non-Final OA | The Jackson Laboratory |
| 17604545 | GENE THERAPIES FOR USHER SYNDROME (USH2A) | Non-Final OA | University of Massachusetts |
| 18197151 | GENETICALLY EDITED ALBINO-RED GERMLINES OF TILAPIA FISH | Final Rejection | The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization |
| 17915548 | AAV CAPSIDS VARIANTS AND USES THEREOF | Final Rejection | Sichuan University |
| 18132164 | COMPOSITIONS, METHODS AND USES FOR IN VITRO AND IN VIVO GENERATION OF FUNCTIONAL THYMIC TISSUE | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
| 16585184 | ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM | Final Rejection | KEIO UNIVERSITY |
| 17345773 | Methods for Cardiac Fibroblast Differentiation of Human Pluripotent Stem Cells | Final Rejection | Wisconsin Alumni Research Foundation |
| 17264752 | GENE THERAPY METHODS TO CONTROL ORGAN FUNCTION | Final Rejection | Cornell University |
| 17550051 | Use of FOXP3 Enhancers to Modulate Regulatory T Cells | Final Rejection | St. Jude Children's Research Hospital, Inc. |
| 17321645 | HIGHLY PARALLEL ASSAYS FOR SIMULTANEOUS IDENTIFICATION OF ANTIBODY SEQUENCES AND BINDING PARTNERS | Non-Final OA | THE UNIVERSITY OF BRITISH COLUMBIA |
| 18155865 | Method for Constructing Ptgds Gene Knockout Rat Model with Spontaneous Kidney Yin Deficiency | Final Rejection | Shaanxi University of Chinese Medicine |
| 17825784 | TOOLS AND METHODS FOR USING CELL DIVISION LOCI TO CONTROL PROLIFERATION OF CELLS | Non-Final OA | Sinai Health System |
| 18301271 | SIMPLE AND RAPID CONSTRUCTION OF RAT MODEL OF CONSTIPATION AND USE THEREOF | Non-Final OA | INFINITUS (CHINA) COMPANY LTD. |
| 17791091 | COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF TRANSCRIPTION | Non-Final OA | OBSIDIAN THERAPEUTICS, INC. |
| 18255525 | HEAVY CHAIN-ONLY ANTIBODIES | Non-Final OA | TRIANNI, INC. |
| 17916370 | COMPOSITIONS AND METHODS FOR REDUCING GRAFT REJECTION IN ALLOGENEIC CELL THERAPY | Non-Final OA | Nanjing Legend Biotech Co., Ltd. |
| 18322723 | SURFACE-ENGINEERED EXTRACELLULAR VESICLES AND THERAPEUTIC USES THEREOF | Non-Final OA | SHIFTBIO INC. |
| 17598154 | COMPOSITIONS, DEVICES, AND METHODS FOR FACTOR VII THERAPY | Non-Final OA | SIGILON THERAPEUTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy